Marriage Counselors in Garden City, KS Accepting Medicare
3 Marriage Counselors found. Showing 1 - 3
 Jimmie C Stewart, TLMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 E Kansas Plz, Garden City, KS 67846 Phone: 620-275-0625 Fax: 620-275-7908 |
Mr. Fernando Rodriguez-infante, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1111 E Spruce St, Garden City, KS 67846 Phone: 620-276-7689 Fax: 620-276-6117 |
Donald Eves Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1603 E Bluff St, Garden City, KS 67846 Phone: 620-260-5333 |
News Archive
New evidence shows that the heart beats to its own drummer
They've uncovered some of the molecular circuitry within the cardiovascular system itself that controls the daily rise and fall of blood pressure and heart rate. The findings might also explain why commonly used diabetes drugs come with cardiovascular benefits, according to the researchers.
New report provides state-by-state analyses of substance abuse, mental illness patterns
A new report providing state-by-state analyses of substance abuse and mental illness patterns reveals that despite wide variations among the states in the types and levels of behavioral health problems they experience - every state suffers from these problems. For example, among those aged 12 and older, Iowa had less than one third the current illicit drug use rate of Rhode Island (4.1 percent vs. 13.3 percent) - yet Iowa's population aged 12 and older was among the group of states with the nation's highest levels of people participating in binge drinking in the past month (27.2 percent).
Researchers find increased risk of breast cancer in women from the industrial accident zone
People living in the Seveso area of Italy, which was exposed to dioxin after an industrial accident in 1976, have experienced an increased risk of developing cancer. Researchers writing in BioMed Central's open access journal Environmental Health found an increased risk of breast cancer in women from the most exposed zone and an excess of lymphatic and hematopoietic tissue neoplasms in all but the least exposed zone.
Positive interim data from Idera Pharmaceuticals' Phase 1 trial of IMO-2125 TLR9 agonist presented at 45th EASL
Idera Pharmaceuticals, Inc. announced today that positive interim data from a Phase 1 clinical trial of IMO-2125, a Toll-like Receptor 9 (TLR9) agonist, in null responder patients with chronic hepatitis C virus (HCV) infection were presented at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL).
› Verified 3 days ago
Dentists
Counselors
Pharmacists
Clinical Social Workers
Psychologists
Occupational Therapists
Marriage Counselors